Literature DB >> 14582041

Hospitalization during advancing chronic kidney disease.

T-Christian H Mix1, Wendy L St peter, Jim Ebben, Jay Xue, Brian J G Pereira, Annamaria T Kausz, Allan J Collins.   

Abstract

BACKGROUND: The care of patients with end-stage renal disease (ESRD) is associated with substantial costs to society, much of which is accounted for by a high rate of hospitalization. However, the influence of declining kidney function on hospitalization as ESRD approaches is not well understood.
METHODS: We performed a retrospective cohort study of national data to evaluate the frequency of hospitalizations among patients with chronic kidney disease (CKD) who reached ESRD and had at least 2 years of Medicare eligibility before initiation of dialysis therapy. The study period for each patient extended from 2 years before to 6 months after the initiation of dialysis therapy.
RESULTS: The study cohort was composed of 109,321 patients with a mean age of 75 years, all of whom initiated long-term dialysis therapy between 1995 and 1998. Mean hospitalization rate was 134 hospitalizations/1,000 patient-months at risk (PMAR). Hospitalization rates gradually increased as ESRD approached, peaking in the 3 months immediately after the initiation of dialysis therapy at 487 hospitalizations/1,000 PMAR. Cause-specific hospitalization rates mirrored this trend and were greatest for placement of vascular access and diagnoses related to cardiovascular (CVD) and infectious disease.
CONCLUSION: Hospitalizations during CKD become more frequent with the approach of ESRD. The majority of these hospitalizations, both before and after the initiation of dialysis therapy, are caused by comorbidity related to CKD. These hospitalizations may be favorably impacted on by heightened attention to the prevention and management of CVD and timely placement of vascular access during CKD.

Entities:  

Mesh:

Year:  2003        PMID: 14582041     DOI: 10.1016/j.ajkd.2003.06.001

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  21 in total

1.  Health economic evaluation of paricalcitol(®) versus cinacalcet + calcitriol (oral) in Italy. [corrected].

Authors:  Mark Nuijten; Daniela P Roggeri; Alessandro Roggeri; Paolo Novelli; Thomas S Marshall
Journal:  Clin Drug Investig       Date:  2015-04       Impact factor: 2.859

2.  Comparative cost-benefit analyses of paricalcitol and calcitriol in stage 4 chronic kidney disease from the perspective of a health plan.

Authors:  Anca Gal-Moscovici; Stuart M Sprague
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

3.  Putting patients at the center of kidney care transitions: PREPARE NOW, a cluster randomized controlled trial.

Authors:  J A Green; P L Ephraim; F F Hill-Briggs; T Browne; T S Strigo; C L Hauer; R A Stametz; J D Darer; U D Patel; K Lang-Lindsey; B L Bankes; S A Bolden; P Danielson; S Ruff; L Schmidt; A Swoboda; P Woods; B Vinson; D Littlewood; G Jackson; J F Pendergast; J St Clair Russell; K Collins; E Norfolk; I D Bucaloiu; S Kethireddy; C Collins; D Davis; J dePrisco; D Malloy; C J Diamantidis; S Fulmer; J Martin; D Schatell; N Tangri; A Sees; C Siegrist; J Breed; A Medley; E Graboski; J Billet; M Hackenberg; D Singer; S Stewart; A Alkon; N A Bhavsar; L Lewis-Boyer; C Martz; C Yule; R C Greer; M Saunders; B Cameron; L E Boulware
Journal:  Contemp Clin Trials       Date:  2018-09-12       Impact factor: 2.226

4.  Hospital Readmission among New Dialysis Patients Associated with Young Age and Poor Functional Status.

Authors:  LaTonya J Hickson; Bjorg Thorsteinsdottir; Priya Ramar; Megan S Reinalda; Cynthia S Crowson; Amy W Williams; Robert C Albright; Macaulay A Onuigbo; Andrew D Rule; Nilay D Shah
Journal:  Nephron       Date:  2018-01-09       Impact factor: 2.847

5.  Rate of Kidney Function Decline and Risk of Hospitalizations in Stage 3A CKD.

Authors:  Yan Xie; Benjamin Bowe; Hong Xian; Sumitra Balasubramanian; Ziyad Al-Aly
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-08       Impact factor: 8.237

6.  Changes in survival among elderly patients initiating dialysis from 1990 to 1999.

Authors:  Sarbjit Vanita Jassal; Lilyanna Trpeski; Naisu Zhu; Stanley Fenton; Brenda Hemmelgarn
Journal:  CMAJ       Date:  2007-10-23       Impact factor: 8.262

7.  Patient Experience with Primary Care Physician and Risk for Hospitalization in Hispanics with CKD.

Authors:  Esteban A Cedillo-Couvert; Jesse Y Hsu; Ana C Ricardo; Michael J Fischer; Ben S Gerber; Edward J Horwitz; John W Kusek; Eva Lustigova; Amada Renteria; Sylvia E Rosas; Milda Saunders; Daohang Sha; Anne Slaven; James P Lash
Journal:  Clin J Am Soc Nephrol       Date:  2018-10-18       Impact factor: 8.237

8.  High burden and unmet patient needs in chronic kidney disease.

Authors:  Leeann Braun; Vipan Sood; Susan Hogue; Bonnie Lieberman; Catherine Copley-Merriman
Journal:  Int J Nephrol Renovasc Dis       Date:  2012-12-13

9.  Temporal evolution of C-reactive protein levels and its association with the incident hospitalization risk among individuals with stage 3-4 chronic kidney disease.

Authors:  Koray Uludag; Gulsah Boz; Tamer Arikan; Ali Ihsan Gunal
Journal:  Int Urol Nephrol       Date:  2021-06-30       Impact factor: 2.370

10.  Hospitalization Trajectories and Risks of ESKD and Death in Individuals With CKD.

Authors:  Anand Srivastava; Xuan Cai; Rupal Mehta; Jungwha Lee; David I Chu; Katherine T Mills; Tariq Shafi; Jonathan J Taliercio; Jesse Y Hsu; Sarah J Schrauben; Milda R Saunders; Clarissa J Diamantidis; Chi-Yuan Hsu; Sushrut S Waikar; James P Lash; Tamara Isakova
Journal:  Kidney Int Rep       Date:  2021-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.